[Intravenous iron-dextran in the elderly].

127 of 1000 patients treated during the first 2 years of this department's operation were found to be anemic. In 69 of them iron deficiency was diagnosed and 54 of them were treated with intravenous iron-dextran (Imferon). It had to be stopped because of adverse effects in 11 of them; 1 of them had a nonfatal anaphylactoid reaction, 4 women, 75-84 years old… CONTINUE READING